DEA’s Diversion Control Division strives to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources. When the safety and health of the American people is in jeopardy, DEA takes action against those who violate the law. Read the latest on these enforcement cases and civil actions.

Former Health Care Worker Sentenced for Fentanyl Thefts (March 29, 2023)

Colorado Pharmacy and Pharmacist Agree to Resolve Allegations that They Unlawfully Filled Dangerous Prescriptions for Controlled Substances (March 27, 2023)

Indianapolis Pharmacy Technician Charged with Controlled Substances Violations (March 24, 2023)

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances (March 21, 2023)

Exton, Pennsylvania Lab Agrees to Pay $125,000 to Resolve Controlled Substances Act Violations (March 17, 2023)

Former Nurse Sentenced for Stealing Opioids from Kansas Hospital (March 13, 2023)

Defendants Convicted and Sentenced in Long-Term Methamphetamine and Oxycodone Drug Trafficking Investigation in Bay County (March 10, 2023)

Nurse at St. Louis County Hospital Sentenced to Four Years of Probation for Fraudulently Obtaining Fentanyl (March 09, 2023)

Greenwood Village Psychiatrist Pleads Guilty to Illegal Distribution of Controlled Substances and Financial Crimes (March 09, 2023)

Indiana Man Sentenced to 5 Years' Probation for Obtaining a Controlled Substance by Deception (March 08, 2023)

Laurence Doud, Former CEO of Pharmaceutical Distributor, Sentenced to 27 Months in Prison for Conspiring to Unlawfully Distribute Controlled Substances and Defrauding the DEA (March 08, 2023)

Pain Clinic Owners Sentenced for Unlawfully Distributing Opioids and Multimillion-Dollar Health Care Fraud (March 7, 2023)

Westmoreland County Doctor Charged with Illegal Prescribing and Fraud (March 1, 2023)